8-K/A: SelectQuote Reports Q4 FY25 Net Income, Strong Healthcare Growth

SelectQuote, Inc. reported a return to consolidated net income of $12.9 million for the fourth quarter of fiscal year 2025, driven by significant growth in its Healthcare Services segment.

Summary

• Consolidated revenue for the fourth quarter of fiscal year 2025 increased to $345.1 million, up from $307.2 million in Q4 FY24.
• The company achieved a consolidated net income of $12.9 million in Q4 FY25, a significant improvement from a net loss of $31.0 million in Q4 FY24.
• Consolidated Adjusted EBITDA for Q4 FY25 was $2.7 million, a decrease from $14.4 million in Q4 FY24.
• The Healthcare Services segment saw substantial growth, with revenue increasing by 47% to $214.0 million and Adjusted EBITDA surging by 1,204% to $11.9 million in Q4 FY25.
• SelectRx members grew by 31% to 108,018 as of June 30, 2025, compared to the prior year.
• The Senior segment experienced a revenue decline of 28% to $82.5 million and a 72% decrease in Adjusted EBITDA to $7.7 million in Q4 FY25.
• Approved Medicare Advantage policies in the Senior segment decreased by 20% to 85,344 in Q4 FY25.
• The Life segment's revenue increased by 14% to $48.0 million in Q4 FY25, while its Adjusted EBITDA slightly decreased by 4% to $6.9 million.
• For the twelve months ended June 30, 2025, total revenue per MA/MS policy increased by 22% to $2,202, primarily due to pharmacy revenue growth.
• Fiscal Year 2026 guidance projects revenue in the range of $1.650 billion to $1.750 billion and Adjusted EBITDA between $120 million and $150 million.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive. While the company returned to net income and showed strong growth in its Healthcare Services segment, the core Senior segment experienced significant declines in revenue and Adjusted EBITDA. The positive future outlook and management's claims of exceeding expectations are balanced by the Q4 consolidated Adjusted EBITDA decline and the issuance of preferred stock, which adds a new layer to the capital structure.

Positives

• Achieved consolidated net income of $12.9 million in Q4 FY25, a significant turnaround from a $31.0 million net loss in Q4 FY24.
• Healthcare Services segment demonstrated robust growth, with revenue up 47% to $214.0 million and Adjusted EBITDA increasing by 1,204% to $11.9 million in Q4 FY25.
• SelectRx membership grew by 31% year-over-year to 108,018 members, indicating successful execution of the growth strategy for this service.
• The Revenue to Customer Acquisition Cost (CAC) multiple improved to 6.1X for the twelve months ended June 30, 2025, up from 4.5X in the prior year, reflecting increased efficiency in lead conversion.
• Management reported delivering financial results well in excess of initial expectations for the third consecutive year, with Adjusted EBITDA outperforming forecasts by over 20% each year.
• The Life segment showed solid revenue growth of 14% to $48.0 million in Q4 FY25 and a 32% increase in Adjusted EBITDA for the full fiscal year 2025.

Negatives

• Consolidated Adjusted EBITDA for Q4 FY25 decreased significantly by 81.3% to $2.7 million compared to $14.4 million in Q4 FY24.
• The Senior segment experienced a substantial decline in revenue by 28% to $82.5 million and a 72% drop in Adjusted EBITDA to $7.7 million in Q4 FY25.
• Approved Medicare Advantage policies in the Senior segment decreased by 20% to 85,344 in Q4 FY25.
• Lifetime Value of Commissions per Medicare Advantage Approved Policy slightly decreased by 1% to $837 in Q4 FY25.
• Total operating expenses per MA/MS policy increased by 27% for the twelve months ended June 30, 2025, driven by higher cost of goods sold-pharmacy revenue.

Risks

• Reliance on a limited number of insurance carrier partners and potential termination of those relationships or failure to develop new ones.
• Existing and future laws and regulations affecting the health insurance market.
• Changes in health insurance products offered by insurance carrier partners and the health insurance market generally.
• Insurance carriers offering products and services directly to consumers.
• Changes to commissions paid by insurance carriers and underwriting practices.
• Competition with brokers, exclusively online brokers, and carriers who sell policies directly to consumers, as well as government-run health insurance exchanges.
• Developments in the U.S. health insurance system.
• Dependence on revenue from the Senior segment and downturns in the senior health, life, automotive, and home insurance industries.
• Ability to develop new offerings and penetrate new vertical markets.
• Risks from third-party products.
• Failure to enroll individuals during the Medicare annual enrollment period.
• Ability to attract, integrate, and retain qualified personnel.
• Dependence on lead providers and ability to compete for leads.
• Failure to obtain and/or convert sales leads to actual sales of insurance policies.
• Access to data from consumers and insurance carriers.
• Accuracy of information provided from and to consumers during the insurance shopping process.
• Cost-effective advertisement through internet search engines.
• Ability to contact consumers and market products by telephone.
• Global economic conditions, including inflation and tariffs.
• Disruption to operations as a result of future acquisitions.
• Significant estimates and assumptions in the preparation of financial statements.
• Impairment of goodwill.
• Existing or potential litigation and other legal proceedings or inquiries, including the Department of Justice action alleging violations of the federal False Claims Act.
• Existing and future indebtedness and ability to maintain compliance with debt covenants.
• Access to additional capital.
• Failure to protect intellectual property and brand.
• Fluctuations in financial results caused by seasonality.
• Accuracy and timeliness of commissions reports from insurance carriers.
• Timing of insurance carriers' approval and payment practices.
• Factors that impact the estimate of the constrained lifetime value of commissions per policyholder.
• Changes in accounting rules, tax legislation, and other legislation.
• Disruptions or failures of technological infrastructure and platform.
• Failure to maintain relationships with third-party service providers.
• Cybersecurity breaches or other attacks involving systems or those of insurance carrier partners or third-party service providers.
• Ability to protect consumer information and other data.
• Failure to market and sell Medicare plans effectively or in compliance with laws.
• Factors related to the pharmacy business, including manufacturing or supply chain disruptions, access to and demand for prescription drugs, contractual reimbursement rates, and regulatory changes or other industry developments.

Future Outlook

For fiscal year 2026, SelectQuote expects consolidated revenue to be in the range of $1.650 billion to $1.750 billion. Adjusted EBITDA is projected to be between $120 million and $150 million. Management anticipates that the strength of its holistic healthcare services model will increasingly drive substantial value for all stakeholders, with diverse revenue streams leading to increasing cash flow and accelerating new growth initiatives.

Management Comments

• "The strength of our holistic healthcare services model was broadly exhibited in fiscal 2025, and we firmly believe the years ahead will increasingly drive substantial value for each of our stakeholders."
• "Policyholders and patients will continue to benefit from our information advantage through tailored advice and healthcare solutions, which ultimately result in better health outcomes."
• "Our insurance and healthcare service partners benefit from better treatment fit and adherence, which eliminates waste and serves to ease the historical trend of rising healthcare costs for Americans."
• "Additionally, we believe our shareholders will benefit as SelectQuote’s diverse breadth of revenues drive increasing cash flow, which will accelerate and compound with new growth initiatives in the future."
• "We are proud to have delivered financial results well in excess of our initial expectations for the 3rd consecutive year. Over that period, our Adjusted EBITDA results have outperformed our forecasts by more than 20% each year."
• "Our leadership and workforce have accomplished these results through significant change in Medicare Advantage in each year. We credit the talent and hard work of our people and are exceedingly proud of the track record SelectQuote has built as an agile, innovative and reliable source of value for Americans seeking healthcare that best fits their needs."

Industry Context

SelectQuote's results highlight a strategic shift towards a 'holistic healthcare services model,' particularly with the strong performance of its Healthcare Services segment and SelectRx pharmacy. This aligns with broader industry trends focusing on integrated patient care, value-based care, and addressing rising healthcare costs through improved adherence and tailored solutions. While the traditional Senior insurance brokerage (Medicare Advantage) segment faced headwinds, the company's ability to leverage its 'information advantage' and expand into healthcare services positions it to capitalize on the growing demand for comprehensive health solutions, especially for the aging demographic.

Comparison to Industry Standards

• NA The filing does not provide specific comparable companies, projects, or industry benchmarks to assess the results against global standards. The analysis is primarily focused on the company's internal performance and guidance.

Legal Proceedings

• The company is subject to existing or potential litigation and other legal proceedings or inquiries, including a Department of Justice action alleging violations of the federal False Claims Act.

Stakeholder Impact

• Shareholders: Potential for increased value through diverse revenue streams and increasing cash flow, as stated by management, but also dilution risk from preferred stock and mixed segment performance.
• Policyholders and Patients: Expected to benefit from tailored advice, healthcare solutions, and better health outcomes through the company's 'information advantage'.
• Insurance and Healthcare Service Partners: Benefit from better treatment fit and adherence, potentially easing rising healthcare costs.
• Employees: Management credits the talent and hard work of its people for achieving results through significant change in Medicare Advantage.

Next Steps

• The company will host a conference call with the investment community on August 21, 2025, to discuss the results.
• Continue to execute on the strategy to grow SelectRx membership and expand the holistic healthcare services model.
• Monitor and manage risks outlined in the forward-looking statements, including those related to the Department of Justice action.

Key Dates

Recommendation

The company's return to net income and robust growth in the Healthcare Services segment are strong positives, demonstrating successful diversification. However, the significant decline in the core Senior segment's revenue and Adjusted EBITDA, coupled with a substantial drop in consolidated Q4 Adjusted EBITDA, presents a mixed picture. While management's positive outlook and claims of exceeding expectations are encouraging, the issuance of Senior Non-Convertible Preferred Stock adds a new layer of financial obligation and potential future dilution. Given these balanced factors, a 'hold' recommendation is appropriate, allowing investors to observe the execution of the FY26 guidance and the continued performance of the diversified business model.

Keywords

SelectQuote, SLQT, SEC Filing, Earnings Report, Financial Results, Medicare Advantage, Healthcare Services, SelectRx, Insurance Brokerage, Life Insurance, Adjusted EBITDA, Revenue Guidance, Q4 2025